Pregnancy in Adult Congenital Heart Disease

Davidson, William R.

doi:10.1001/jamacardio.2017.0365

Cited by 3 publications

(1 citation statement)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Moreover, these infants were more likely to experience a growth restriction due to the medications taken by women with CHD or the mothers' comorbidities, such as HF. Advances in fetal echocardiography have improved prenatal diagnosis of CHD and allowed better delivery and perinatal management (15,16). It is also very important to monitor and follow pregnant women with CHD using echocardiography (17,18).…”

Section: Discussionmentioning

confidence: 99%

Pregnancy Complications and Outcomes Among Women With Congenital Heart Disease in Beijing, China

Liu

Zhang

et al. 2022

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

ObjectiveTo conduct a comparative analysis of the complications and outcomes in pregnant women with and without congenital heart disease (CHD) in Beijing, China.MethodsWe compared pregnancy-related complications and outcomes experienced by women with and without CHD throughout 19,424 deliveries in Beijing Anzhen Hospital between 2010 and 2019, including cardiovascular and obstetric factors, fetal events, delivery methods, and other complications over a mean 5-years post-delivery follow-up period.ResultsThere were 1,040 women with CHD (5.35% of all deliveries). Compared to women without CHD, these women had longer hospital stays (7.83 ± 4.65 vs. 4.93 ± 3.26 days) and a higher death rate (1.92 vs. 0.02%). They also had a greater risk of comorbidities, including pre-term delivery (odds ratio: 13.65 vs. 6.71), heart failure (odds ratio: 4.90 vs. 0.40), and arrhythmia (odds ratio 12.69 vs. 4.69). Pulmonary hypertension, New York Heart Association functional class III~IV, and no congenital heart disease surgery prior to pregnancy were associated with adverse events such as cesarean section, pre-term delivery, and heart failure. The fetuses of mothers with CHD were more likely to be born pre-term (odds ratio: 13.65 vs. 6.71) and have low birth weight (odds ratio: 8.56 vs. 4.36). Eleven infants (1.82%) born to mothers with CHD and four infants (0.64%) born to mothers without CHD were diagnosed with CHD.ConclusionsWomen with CHD generally increase maternal and infant risk during pregnancy and the perinatal period. Pulmonary hypertension, decrease in cardiac function, and no previous CHD surgery increase the risk in women with CHD. Greater attention should be paid to pregnant women with CHD and their fetuses, newborns.

show abstract

Section: Discussionmentioning

confidence: 99%

Pregnancy Complications and Outcomes Among Women With Congenital Heart Disease in Beijing, China

Liu

Zhang

et al. 2022

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

show abstract

Pregnancy Outcomes in Women With Heart Disease

Silversides

Grewal

Mason

et al. 2018

Journal of the American College of Cardiology

477

286

View full text Add to dashboard Cite

show abstract

Successful totally transthoracic echocardiography guided transcatheter device closure of atrial septal defect in pregnant women

Chen

Cao

Zhang

et al. 2019

WJCC

View full text Add to dashboard Cite

BACKGROUND Transcatheter device closure of atrial septal defect (ASD) guided by fluoroscopy and/or transesophageal echocardiography is a mature technology. Little study has focused on whether the technology can be guided totally by transthoracic echocardiography (TTE), even in pregnant women with ASD. AIM To evaluate the safety and efficacy of totally TTE guided transcatheter device closure of ASD in pregnant women. METHODS Six pregnant women (gestational age 20-26 wk) with ASD underwent transcatheter device closure totally guided by TTE at our cardiac center from January 2015 to August 2017. A routine transcatheter procedure without fluoroscopy or intubation and a domestic occluder were used in this study. RESULTS All patients had successful closure with good clinical results, and the overall immediate complete closure rate was 100%. The size of the occluder deployed ranged from 20 to 32 mm (26.7 ± 4.3 mm), the procedure time ranged from 30 to 50 min (41.7 ± 7.5 min), and the length of hospital stay was 2-3 d (mean 2.2 ± 0.4 d). There were no serious cardiovascular related complications, and transient arrhythmias occurred in one patient during the procedure. During the follow-up period (3 mo to 2 years), no occluder dislodgement, residual fistulas, or thromboses occurred. All of the patients underwent vaginal delivery between 36 and 38 wk of gestation. CONCLUSION Totally TTE guided transcatheter device closure of ASD in pregnant women may be safe and effective.

show abstract

Pregnancy in Adult Congenital Heart Disease

Cited by 3 publications

References 10 publications

Pregnancy Complications and Outcomes Among Women With Congenital Heart Disease in Beijing, China

Pregnancy Complications and Outcomes Among Women With Congenital Heart Disease in Beijing, China

Pregnancy Outcomes in Women With Heart Disease

Successful totally transthoracic echocardiography guided transcatheter device closure of atrial septal defect in pregnant women

Contact Info

Product

Resources

About